Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Agents for allergic diseases in development by Dainippon Ink & Chemicals

Sep. 10, 1999

German collaboration yields new inhibitors of human tryptase

Sep. 7, 1999

Glaxo Wellcome patents improved adenosine A2A receptor agonists as antiinflammatory agents

Sep. 6, 1999

HMR and Sepracor resolve issues relating to fexofenadine

Sep. 3, 1999

New phenylethanolamine bronchodilators synthesized at Chinese university

Sep. 2, 1999

International patent covers Darwin Discovery's new PDE4/TNF inhibitors

Sep. 2, 1999

LeukoSite, Kyowa Hakko collaborate on the study of chemokine receptor antagonists

Aug. 30, 1999

Structural Bioinformatics receives SBIR grant for asthma treatment

Aug. 26, 1999

MRS-1595: a novel adenosine antagonist selective for the A2B receptor

Aug. 25, 1999

Cystic Fibrosis Foundation awards research grant to PathoGenesis

Aug. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...